Package 58118-0502-8

Brand: buprenorphine

Generic: buprenorphine
NDC Package

Package Facts

Identity

Package NDC 58118-0502-8
Digits Only 5811805028
Product NDC 58118-0502
Description

30 TABLET in 1 BLISTER PACK (58118-0502-8)

Marketing

Marketing Status
Marketed Since 2022-10-07
Brand buprenorphine
Generic buprenorphine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBLINGUAL"], "spl_id": "0e859e75-928c-e576-e063-6294a90a8421", "openfda": {"unii": ["56W8MW3EN1"], "rxcui": ["351265"], "spl_set_id": ["2181e700-caa1-48c4-90ce-60fec053ba6a"], "manufacturer_name": ["Clinical Solutions Wholesale, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (58118-0502-8)", "package_ndc": "58118-0502-8", "marketing_start_date": "20221007"}], "brand_name": "BUPRENORPHINE", "product_id": "58118-0502_0e859e75-928c-e576-e063-6294a90a8421", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "58118-0502", "dea_schedule": "CIII", "generic_name": "BUPRENORPHINE", "labeler_name": "Clinical Solutions Wholesale, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPRENORPHINE", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA207276", "marketing_category": "ANDA", "marketing_start_date": "20171025", "listing_expiration_date": "20261231"}